In this podcast, part 1 of a 3-part series, our experts in the Digital FAWG tackle the question of: “How do you define omnichannel?”
In the second podcast of this two-part series, we will discuss communicating the value of Field Medical to external stakeholders.
In this first podcast, the first of a two-part series, we will discuss communicating the value of Field Medical to internal stakeholders.
In this podcast, we explore best practices for gathering content (beyond simply creating it yourself!), and making content accessible in modern, personalized platforms.
Hosted by experienced medical communications experts and industry leaders, this webinar covers how a holistic approach towards a Publication Extender Strategy can elevate the scientific exchange between the industry and HCPs.
Pharmaceutical companies can make information easily accessible and easy to understand with publication extenders, as HCPs are in need of short form, bite-sized information to aid their medical decision making. However, in an age of information overload, a personalized, relevant approach is necessary to reach and engage them effectively.
Current practice is based on one-off, ad-hoc creation of publication extenders, and many important facets of effective communication strategies are often overlooked. The approach presented during this webinar emphasizes the importance of defining clear audience segments, using omnichannel methodology, and learning how to reach a wider audience through a variety of formats.
Participants in this webinar will learn about the benefits of a holistic Publication Extender Strategy and gain practical insights on how to implement one effectively.
Join us for this informative webinar to stay ahead of the curve in the fast-paced world of digital medical communications and learn how to leverage the power of the holistic Publication Extender Strategy to create compelling content and inform, educate, and engage HCPs more effectively.
At the end of the session, you will be able to:​
In this podcast, two data specialists discuss the ways in which Medical Affairs professionals can use this data to discover your next generation of researchers, those influencers whose voices are heard on Twitter, and how your KOLs are interacting with others online.
Over the last decade as the requirements for evidence to support the various dimensions of value assessment of medicines have strengthened and the breadth of audiences has increased, Medical Affairs is realizing more potential and bringing together its capabilities for strategy, science, and communication in powerful ways. In the rapidly evolving regulatory, technological, and scientific environment, the Medical Affairs function is uniquely positioned to coordinate the identification, prioritization, strategic planning, execution and communication of the broad variety of high-quality evidence necessary to fulfill unmet needs of clinicians, payers, reimbursement agencies, policy makers, advocacy groups, and patients.
This Standard and Guidance is intended to inform learners about the Evidence Generation function, strategic direction, and operations across multiple geographies.
Customer engagements for Medical Affairs has evolved rapidly post COVID-19. Hybrid is the future and that brings with it new challenges, most notably in sustaining engagements with the KOLs to become unbiased scientific partners of choice. As a result, there have been shifts in strategies: newer roles, newer stakeholders to be engaged, and more data and information collected.
There is no one-size-fits-all approach. The intent of this webinar will be to have a discussion on which strategies are working, and how leading companies are defining success for field medical teams in hybrid engagements.
The growth of Real-World Evidence (RWE) from sources including patient registries, claims data, electronic medical records, digital health technologies and more has powered the ability of Medical Affairs to drive patient outcomes. Here, the MAPS Executive Consortium describes how.